Skip to main
TCRR
TCRR logo

Tcr2 Therapeutics (TCRR)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Tcr2 Therapeutics (TCRR) Stock

About Tcr2 Therapeutics (TCRR)

TCR2 Therapeutics, Inc. is a clinical-stage cell therapy company, which engages in the development of biological drugs and engineering T-cells for cancer therapy. It is also involved in the research and collaboration with academic laboratories and industry partners in the field of T-cell immunology, cell therapy, gene editing, and process development. The company was founded by Patrick A. Baeuerle...read more
Market cap$58.11M
Today's volume
Revenue (TTM)
Avg. daily volume679.61K
EBITDA (TTM)
Open
Price / earnings ratio-0.35x
Today's range
Debt / equity
52 week range$0.82 - $3.88
5 year debt / equity2.1x
Beta (LTM)0.98x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio
Ex-dividend date
Next earningsMay 11, 2023
Dividend payable date

Frequently Asked Questions (FAQ)

As of Jun 24, 2025, the market cap for TCRR stock is $58.11M

The current P/E ratio for TCRR stock is -0.35

The 52-week high for TCRR stock is $3.88. The current TCRR stock price $undefined is 100.00% below its 52-week high

The 52-week low for TCRR stock is $0.82. The current TCRR stock price $undefined has increased 100.00% from its 52-week low

No, the TCRR stock does not pay dividends to its shareholders

How to buy TCRR stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in TCRR stock

    Navigate to the Explore page. Then, type TCRR into the search bar. When you see TCRR stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased TCRR stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Tcr2 Therapeutics Stock Earnings

The value each TCRR share was expected to gain vs. the value that each TCRR share actually gained.

Tcr2 Therapeutics (TCRR) reported Q1 2023 earnings per share (EPS) of -$1.03, missing estimates of -$0.68 by 51.47%. In the same quarter last year, Tcr2 Therapeutics's earnings per share (EPS) was -$0.76. Tcr2 Therapeutics is expected to release next earnings on 05/11/2023, with an earnings per share (EPS) estimate of $0.

Buy Tcr2 Therapeutics (TCRR) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.